Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fruquintinib in Patients With Metastatic Colorectal Cancer: A Prospective, Multicenter, Observational Study

NCT06787105 is registered in ClinicalTrials.gov with iOMEDICO AG as lead sponsor.

NCT NCT06787105
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06787105 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fruquintinib in Patients With Metastatic Colorectal Cancer: A Prospective, Multicenter, Observational Study
Lead sponsor
iOMEDICO AG
Phase
Observational
Overall status
Recruiting
Start date
February 17, 2025
Completion date
December 31, 2027
Enrollment
150 (estimated)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer (mcrc)